Related by context. Frequent words. (Click for all words.) 72 Improves Survival 72 Renal Cell Carcinoma 71 Clinical Trial Results 71 Gastric Cancer 69 Lung Cancer Patients 69 Tumor Growth 68 Prostate Cancer Patients 68 Drug Candidate 68 Bladder Cancer 68 Breast Cancer Treatment 67 Cancer Cells 67 Breast Cancer Patients 67 Blood Thinner 67 Advanced Prostate Cancer 67 Autoimmune Disease 67 Reduces Risk 67 Preclinical Data 67 Single Dose 67 Monoclonal Antibody 67 RNAi Therapeutics 67 Recombinant Human 67 Study Demonstrates 67 Chronic Lymphocytic Leukemia 67 Patients Treated 67 Prostate Cancer Treatment 66 Receives Orphan Drug Designation 66 Autoimmune Diseases 66 Inhibits 66 Patients Undergoing 66 Ischemic 66 Phase III Trial 66 Inflammatory Diseases 66 Early Diagnosis 66 Low Dose 66 Hepatocellular Carcinoma 66 Holds Promise 66 Blood Vessel 66 Postmenopausal Women 66 Cholesterol Drug 66 Meta Analysis 66 Significantly Improves 66 Dasatinib 66 Help Predict 66 Cancer Vaccines 66 Stomach Cancer 66 Gene Mutation 65 Small Molecule 65 Overactive Bladder 65 Cyclophosphamide 65 Shows Promise 65 Insulin Resistance 65 Cognitive Decline 65 Phase III Clinical Trial 65 Targeted Therapy 65 Hormone Therapy 65 Post Operative 65 Combination Therapy 65 Angiographic 65 Acute Ischemic Stroke 65 Brain Function 65 Blood Vessels 65 Embolization 65 Patient Enrollment 64 Heart Failure Patients 64 Cancer Treatments 64 Cholesterol Drugs 64 Cholesterol Levels 64 Chronic Hepatitis C 64 Eculizumab 64 Increases Risk 64 Significantly Reduces 64 Prostate Cancer Risk 64 Pivotal Phase III 64 Antifungal 64 Metastatic Melanoma 64 Urinary Incontinence 64 Announces FDA Clearance 64 Diabetic Patients 64 Glycemic Control 64 Currency Majors Technical 64 Chronic Hepatitis B 64 Completes Enrollment 64 Breast Reconstruction 64 Pulmonary Arterial Hypertension 64 Suppresses 64 Pivotal Study 64 Thyroid Cancer 64 Benign Prostatic Hyperplasia 64 Epratuzumab 64 Metastases 64 Stem Cell Transplant 63 Monotherapy 63 Brain Cells 63 Allergic Rhinitis 63 Aliskiren 63 Brain Tumors 63 Presents Positive 63 Elderly Patients 63 Drug Resistant 63 Newly Diagnosed 63 FDA Clears